Australië - Engels - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - lauromacrogol 400, quantity: 40 mg - injection, solution - excipient ingredients: ethanol; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; water for injections - indications: the solutions are indicated for the treatment of varicose veins (up to 6mm diameter) of the lower limbs by compression sclerotherapy.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - lauromacrogol 400, quantity: 20 mg - injection, solution - excipient ingredients: ethanol; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; water for injections - indications: the solutions are indicated for the treatment of varicose veins (up to 6mm diameter) of the lower limbs by compression. sclerotherapy.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - lauromacrogol 400, quantity: 10 mg - injection, solution - excipient ingredients: ethanol; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; water for injections - indications: the solutions are indicated for the treatment of varicose veins (up to 6mm diameter) of the lower limbs by compression sclerotherapy.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium chloride, quantity: 234 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 01 january 1991 : as an additive to parenteral fluids in patients who have specific electrolyte needs for sodium or chloride ions. as a sclerosing agent for small symptomatic varicose veins.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - sodium chloride, quantity: 200 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - indications as at 19 february 1993 : as an additive to parenteral fluids in patients who have specific electrolyte needs. as a sclerosing agent for small symptomatic varicose veins.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

medical specialties australasia pty ltd - 47535 - varicose vein lasing procedure kit - indicated for use in the treatment of: varicose veins and varicosities associated with superficial vein reflux of the great saphenous vein; and/or with veins in the lower limbs (or lower extremity) with superficial reflux; and/or treatment of incompetent (i.e. refluxing) perforator veins (ipvs).

Australië - Engels - Department of Health (Therapeutic Goods Administration)

australian naturalcare products pty ltd - aesculus hippocastanum,centella asiatica,ruscus aculeatus -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

youngo international pty ltd - chondroitin sulfate - shark,glucosamine sulfate-potassium chloride complex -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - estriol, quantity: 1 mg/g - cream - excipient ingredients: sodium hydroxide; stearyl alcohol; lactic acid; cetyl esters wax; purified water; chlorhexidine hydrochloride; sorbitan monostearate; octyldodecanol; glycerol; polysorbate 60; cetyl alcohol - indications as at 18 december 2001. vulvo-vaginal complaints due to oestrogen deficiency associated with the climacteric and the postmenopause or after ovariectomy: atrophic vaginitis. puritis vulvae. dyspareunia due to vulvo-vaginal atrophy. as auxiliary therapy in the treatment of vaginal infections. as pre-operative therapy for vulvo-vaginal surgery and during subsequent convalescence. ulcers in the case of prolapse of the uterus or vagina. to avoid misinterpretation of a cytological smear.